After surviving prostate most cancers, Andy Winnegar obtained a prognosis of power lymphocytic leukemia (CLL) in 2021. Make amends for Andy's blogs right here!I’m...
Dr. Lorenzo Cohen and Alison Jefferies talk about small but significant adjustments that sufferers could make to their residence setting to foster a...
Dr. Christina Poh, a hematologist-oncologist, mentioned the medical trial that led to the FDA approval of Monjuvi (tafasitamab-cxix) together with Revlimid (lenalidomide) and...
Dr. Nicholas James shares why it’s essential to determine which sufferers with high-risk, non-metastatic prostate most cancers will profit from intensified remedy.Figuring out...
Troy Anderson, a follicular lymphoma survivor, shared how becoming a member of a scientific trial at Fred Hutch, positioned in Seattle, Washington, modified...
